Q2 2016 Holdings
Filed 2016-08-05 | 39 holdings | $195.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ardelyx Inc(ARDX) | COM | 039697107 | $103.0M | 11,792,631 | 52.6% |
| Adaptimmune Therapeutics(ADAPY) | ADR | 00653A107 | $80.5M | 9,880,999 | 41.2% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $7.1M | 2,546,843 | 3.6% |
| Champions Oncology Inc(CSBR) | COM | 15870P307 | $3.4M | 1,562,500 | 1.7% |
| Tesaro Inc | COM | 881569107 | $863.6K | 10,275,113 | 0.4% |
| Groupon Inc | COM CL A | 399473107 | $107.6K | 33,109,905 | 0.1% |
| Senseonics Holdings Inc(SENS1GBP) | COM | 81727U105 | $103.4K | 26,303,189 | 0.1% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $102.6K | 3,506,649 | 0.1% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $64.1K | 6,260,851 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $62.4K | 8,584,128 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $48.7K | 660,428 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $41.5K | 1,792,207 | 0.0% |
| Care COM Inc(CRCMGBP) | COM | 141633107 | $38.1K | 3,260,989 | 0.0% |
| Proteostasis Therapeutics Inc | COM | 74373B109 | $37.5K | 3,095,240 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM | 528872302 | $34.2K | 2,382,286 | 0.0% |
| Endologix Inc | COM | 29266S106 | $31.0K | 2,490,204 | 0.0% |
| Aerohive Networks Inc(HIVEEUR) | COM | 007786106 | $31.0K | 4,681,455 | 0.0% |
| Trevena Inc | COM | 89532E109 | $24.0K | 3,811,691 | 0.0% |
| Achaogen Inc | COM | 004449104 | $17.9K | 4,715,128 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $17.2K | 2,207,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $15.6K | 1,139,890 | 0.0% |
| Mirna Therapeutics Inc | COM | 60470J103 | $12.7K | 2,974,811 | 0.0% |
| Cascadian Therapeutics Inc | COM | 14740B101 | $10.1K | 10,750,000 | 0.0% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | COM | 053588109 | $9.9K | 10,362,694 | 0.0% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $8.5K | 2,141,308 | 0.0% |
| Tracon Pharmaceuticals Inc | COM | 89237H100 | $8.3K | 1,889,652 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM | 766559603 | $7.2K | 3,243,150 | 0.0% |
| Akari Therapeutics PLC | ADR | 00972G108 | $6.1K | 452,167 | 0.0% |
| Zhone Technologies Inc | COM | 98950P884 | $5.7K | 4,781,290 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $4.8K | 2,520,316 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM | 867328601 | $4.3K | 7,789,644 | 0.0% |
| Arca Biopharma Inc | COM PAR $.001 | 00211Y407 | $4.2K | 1,460,209 | 0.0% |
| Zosano Pharma Corp | COM | 98979H103 | $2.7K | 2,158,543 | 0.0% |
| Roka Bioscience Inc | COM | 775431109 | $1.8K | 3,220,433 | 0.0% |
| Orexigen Therapeutics Inc | COM | 686164104 | $1.6K | 370,900 | 0.0% |
| Cerecor Inc | COM | 15671L109 | $1.3K | 595,435 | 0.0% |
| Agile Therapeutics PLC(AGRXUSD) | COM | 00847L100 | $1.0K | 133,488 | 0.0% |
| Catalyst Biosciences Inc | COM | 14888D109 | $992 | 652,380 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $921 | 66,245 | 0.0% |